Shibasaki H - Search Results

1

Effect of UGT1A1, CYP3A and CES Activities on the Pharmacokinetics of Irinotecan and its Metabolites in Patients with UGT1A1 Gene Polymorphisms.

Yokokawa A, Kaneko S, Endo S, Minowa Y, Ayukawa H, Hirano R, Nagashima F, Naruge D, Okano N, Kobayashi T, Kawai K, Furuse J, Furuta T, Shibasaki H. Yokokawa A, et al. Among authors: shibasaki h. Eur J Drug Metab Pharmacokinet. 2021 Mar;46(2):317-324. doi: 10.1007/s13318-021-00675-3. Epub 2021 Feb 23. Eur J Drug Metab Pharmacokinet. 2021. PMID: 33619631

2

Simultaneous determination of stable isotopically labelled L-histidine and urocanic acid in human plasma by stable isotope dilution mass spectrometry.

Furuta T, Katayama M, Shibasaki H, Kasuya Y. Furuta T, et al. Among authors: shibasaki h. J Chromatogr. 1992 May 8;576(2):213-9. doi: 10.1016/0378-4347(92)80195-v. J Chromatogr. 1992. PMID: 1400709

3

Stereochemical aspects in the enantioselective synthesis of cortisone by the indan synthon method.

Shibasaki H, Furuta T, Kasuya Y. Shibasaki H, et al. Steroids. 1992 Jul;57(7):325-7. doi: 10.1016/0039-128x(92)90051-a. Steroids. 1992. PMID: 1412569 No abstract available.

4

Stable isotope dilution mass spectrometry for the simultaneous determination of cortisol, cortisone, prednisolone and prednisone in plasma.

Shibasaki H, Furuta T, Kasuya Y. Shibasaki H, et al. J Chromatogr. 1992 Sep 2;579(2):193-202. doi: 10.1016/0378-4347(92)80382-z. J Chromatogr. 1992. PMID: 1429966

5

Simultaneous determination of cortisol and cortisone in human plasma by stable-isotope dilution mass spectrometry.

Shibasaki H, Arai I, Furuta T, Kasuya Y. Shibasaki H, et al. J Chromatogr. 1992 Apr 15;576(1):47-52. doi: 10.1016/0378-4347(92)80173-n. J Chromatogr. 1992. PMID: 1500456

6

Preparation of multiply deuterium-labeled cortisol.

Shibasaki H, Furuta T, Kasuya Y. Shibasaki H, et al. Steroids. 1992 Jan;57(1):13-7. doi: 10.1016/0039-128x(92)90090-v. Steroids. 1992. PMID: 1585388

7

Reversible stepwise mechanism involving a carbanion intermediate in the elimination of ammonia from L-histidine catalyzed by histidine ammonia-lyase.

Furuta T, Takahashi H, Shibasaki H, Kasuya Y. Furuta T, et al. Among authors: shibasaki h. J Biol Chem. 1992 Jun 25;267(18):12600-5. J Biol Chem. 1992. PMID: 1618765 Free article.

8

Evaluation of the utility of a proposed method for correcting for intrasubject variability in metabolic clearance in the bioavailability assessment of theophylline.

Kasuya Y, Furuta T, Shibasaki H, Shimota H. Kasuya Y, et al. Among authors: shibasaki h. J Pharmacokinet Biopharm. 1991 Feb;19(1):113-6. doi: 10.1007/BF01062195. J Pharmacokinet Biopharm. 1991. PMID: 2023107 No abstract available.

9

Diurnal rhythm in the plasma concentration of cortisol in paediatric patients with orthostatic dysregulation.

Shibasaki H, Furuta T, Kasuya Y, Okabe T, Katoh T, Kogo T, Hirayama T. Shibasaki H, et al. Biomed Environ Mass Spectrom. 1990 Apr;19(4):225-9. doi: 10.1002/bms.1200190404. Biomed Environ Mass Spectrom. 1990. PMID: 2340360

10

Pharmacokinetics of stable isotopically labeled L-histidine in humans and the assessment of in vivo histidine ammonia lyase activities.

Furuta T, Okamiya K, Shibasaki H, Kasuya Y. Furuta T, et al. Among authors: shibasaki h. Drug Metab Dispos. 1996 Jan;24(1):49-54. Drug Metab Dispos. 1996. PMID: 8825190

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

697 results

Search Page

Filters